|
1
|
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria.
|
Circulation
|
2010
|
6.71
|
|
2
|
Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.
|
J Am Coll Cardiol
|
2008
|
4.63
|
|
3
|
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria.
|
Eur Heart J
|
2010
|
4.13
|
|
4
|
A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension.
|
J Am Coll Cardiol
|
2012
|
3.57
|
|
5
|
Dexmedetomidine sedation leading to refractory cardiogenic shock.
|
Anesth Analg
|
2008
|
3.48
|
|
6
|
Atrial fibrillation and obesity--results of a meta-analysis.
|
Am Heart J
|
2007
|
2.86
|
|
7
|
Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial.
|
J Am Coll Cardiol
|
2011
|
2.84
|
|
8
|
Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study.
|
Heart Rhythm
|
2009
|
2.82
|
|
9
|
Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA study.
|
J Am Coll Cardiol
|
2007
|
2.79
|
|
10
|
Echocardiography for cardiac resynchronization therapy: recommendations for performance and reporting--a report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society.
|
J Am Soc Echocardiogr
|
2008
|
2.42
|
|
11
|
Acute termination of human atrial fibrillation by identification and catheter ablation of localized rotors and sources: first multicenter experience of focal impulse and rotor modulation (FIRM) ablation.
|
J Cardiovasc Electrophysiol
|
2012
|
2.40
|
|
12
|
Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks.
|
Circulation
|
2002
|
2.16
|
|
13
|
Predictors of response to cardiac resynchronization therapy in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT).
|
Circulation
|
2011
|
2.08
|
|
14
|
Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial.
|
Circulation
|
2009
|
1.87
|
|
15
|
Catheter cryoablation of supraventricular tachycardia: results of the multicenter prospective "frosty" trial.
|
Heart Rhythm
|
2004
|
1.86
|
|
16
|
Percent right ventricular pacing predicts outcomes in the DAVID trial.
|
Heart Rhythm
|
2005
|
1.83
|
|
17
|
Prevalence, predictors, and prognosis of atrial fibrillation early after pulmonary vein isolation: findings from 3 months of continuous automatic ECG loop recordings.
|
J Cardiovasc Electrophysiol
|
2009
|
1.82
|
|
18
|
Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.
|
Circulation
|
2006
|
1.81
|
|
19
|
Influence of left ventricular lead location on outcomes in the COMPANION study.
|
J Cardiovasc Electrophysiol
|
2009
|
1.72
|
|
20
|
Robotically assisted left ventricular epicardial lead implantation for biventricular pacing.
|
J Am Coll Cardiol
|
2003
|
1.64
|
|
21
|
Comparative safety of periablation anticoagulation strategies for atrial fibrillation: data from a large multicenter study.
|
Pacing Clin Electrophysiol
|
2014
|
1.60
|
|
22
|
Ganglionated plexus ablation vs linear ablation in patients undergoing pulmonary vein isolation for persistent/long-standing persistent atrial fibrillation: a randomized comparison.
|
Heart Rhythm
|
2013
|
1.57
|
|
23
|
Intracardiac ultrasound detection of thrombus on transseptal sheath: incidence, treatment, and prevention.
|
J Cardiovasc Electrophysiol
|
2005
|
1.53
|
|
24
|
Initial independent outcomes from focal impulse and rotor modulation ablation for atrial fibrillation: multicenter FIRM registry.
|
J Cardiovasc Electrophysiol
|
2014
|
1.53
|
|
25
|
Long-term implications of cumulative right ventricular pacing among patients with an implantable cardioverter-defibrillator.
|
Heart Rhythm
|
2010
|
1.47
|
|
26
|
Does cardiac resynchronization therapy provide unrecognized benefit in patients with prolonged PR intervals? The impact of restoring atrioventricular synchrony: an analysis from the COMPANION Trial.
|
Heart Rhythm
|
2011
|
1.47
|
|
27
|
Hypertension and hypertensive heart disease are associated with increased ostial pulmonary vein diameter.
|
J Cardiovasc Electrophysiol
|
2005
|
1.45
|
|
28
|
Implantable cardioverter-defibrillator therapy and risk of congestive heart failure or death in MADIT II patients with atrial fibrillation.
|
Heart Rhythm
|
2006
|
1.43
|
|
29
|
Long-term outcome following successful pulmonary vein isolation: pattern and prediction of very late recurrence.
|
J Cardiovasc Electrophysiol
|
2008
|
1.35
|
|
30
|
The World Trade Center attack: increased frequency of defibrillator shocks for ventricular arrhythmias in patients living remotely from New York City.
|
J Am Coll Cardiol
|
2004
|
1.28
|
|
31
|
ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs).
|
Europace
|
2012
|
1.18
|
|
32
|
Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
|
J Am Coll Cardiol
|
2006
|
1.15
|
|
33
|
Time-dependent benefit of preventive cardiac resynchronization therapy after myocardial infarction.
|
Eur Heart J
|
2010
|
1.00
|
|
34
|
Postoperative atrial fibrillation: a billion-dollar problem.
|
J Am Coll Cardiol
|
2004
|
0.96
|
|
35
|
The utility of 12-lead Holter monitoring in patients with permanent atrial fibrillation for the identification of nonresponders after cardiac resynchronization therapy.
|
J Am Coll Cardiol
|
2009
|
0.93
|
|
36
|
Termination of persistent atrial fibrillation resistant to cardioversion by a single radiofrequency application.
|
Pacing Clin Electrophysiol
|
2003
|
0.90
|
|
37
|
Long-term ECG monitoring using an implantable loop recorder for the detection of atrial fibrillation after cavotricuspid isthmus ablation in patients with atrial flutter.
|
Heart Rhythm
|
2013
|
0.88
|
|
38
|
Resumption of sinus rhythm in patients with heart failure and permanent atrial fibrillation undergoing cardiac resynchronization therapy: a longitudinal observational study.
|
Eur Heart J
|
2010
|
0.87
|
|
39
|
Ambulatory external electrocardiographic monitoring: focus on atrial fibrillation.
|
J Am Coll Cardiol
|
2011
|
0.85
|
|
40
|
Value of the signal-averaged electrocardiogram in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
|
Heart Rhythm
|
2010
|
0.84
|
|
41
|
Desperately seeking a randomized clinical trial of resynchronization therapy for patients with heart failure and atrial fibrillation.
|
J Am Coll Cardiol
|
2006
|
0.83
|
|
42
|
Does atrial fibrillation burden measured by continuous monitoring during the blanking period predict the response to ablation at 12-month follow-up?
|
Heart Rhythm
|
2012
|
0.83
|
|
43
|
Cryoballoon versus radiofrequency for pulmonary vein re-isolation after a failed initial ablation procedure in patients with paroxysmal atrial fibrillation.
|
J Cardiovasc Electrophysiol
|
2012
|
0.83
|
|
44
|
Progression of atrial fibrillation after a failed initial ablation procedure in patients with paroxysmal atrial fibrillation: a randomized comparison of drug therapy versus reablation.
|
Circ Arrhythm Electrophysiol
|
2013
|
0.82
|
|
45
|
Catheter versus surgical ablation of atrial fibrillation after a failed initial pulmonary vein isolation procedure: a randomized controlled trial.
|
J Cardiovasc Electrophysiol
|
2013
|
0.81
|
|
46
|
Acute conversion of persistent atrial fibrillation during dofetilide initiation.
|
Pacing Clin Electrophysiol
|
2007
|
0.81
|
|
47
|
Correlation of QT interval correction methods during atrial fibrillation and sinus rhythm.
|
Am J Cardiol
|
2013
|
0.80
|
|
48
|
Botulinum toxin injection in epicardial fat pads can prevent recurrences of atrial fibrillation after cardiac surgery: results of a randomized pilot study.
|
J Am Coll Cardiol
|
2014
|
0.79
|
|
49
|
The SELF pathway for the management of syncope.
|
Crit Pathw Cardiol
|
2006
|
0.79
|
|
50
|
The rationale for nontransvenous leads and cardiac resynchronization devices.
|
Pacing Clin Electrophysiol
|
2003
|
0.79
|
|
51
|
Midterm Follow-up of Robotic Biventricular Pacing Demonstrates Excellent Lead Stability and Improved Response Rates.
|
Innovations (Phila)
|
2006
|
0.78
|
|
52
|
Randomized study of early intravenous esmolol versus oral beta-blockers in preventing post-CABG atrial fibrillation in high risk patients identified by signal-averaged ECG: results of a pilot study.
|
Ann Noninvasive Electrocardiol
|
2002
|
0.78
|
|
53
|
Recurrence rate of atrial flutter after initial presentation in patients on drug treatment.
|
Am J Cardiol
|
2003
|
0.78
|
|
54
|
Long-term outcome of leads and patients following robotic epicardial left ventricular lead placement for cardiac resynchronization therapy.
|
Pacing Clin Electrophysiol
|
2010
|
0.78
|
|
55
|
Pulmonary vein isolation alone in patients with persistent atrial fibrillation: an ablation strategy facilitated by antiarrhythmic drug induced reverse remodeling.
|
J Cardiovasc Electrophysiol
|
2010
|
0.78
|
|
56
|
Intravenous versus oral beta-blockers for prevention of post-CABG atrial fibrillation in high-risk patients identified by signal-averaged ECG: lessons of a pilot study.
|
Card Electrophysiol Rev
|
2003
|
0.77
|
|
57
|
Role of electrophysiologic studies, signal-averaged electrocardiography, heart rate variability, T-wave alternans, and loop recorders for risk stratification of ventricular arrhythmias.
|
Am J Geriatr Cardiol
|
2005
|
0.77
|
|
58
|
Patterns of atrial fibrillation after coronary artery bypass surgery.
|
Ann Noninvasive Electrocardiol
|
2006
|
0.77
|
|
59
|
ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs).
|
Ann Noninvasive Electrocardiol
|
2012
|
0.77
|
|
60
|
Acute and chronic sequelae of ventricular dyssynchrony.
|
Prog Cardiovasc Dis
|
2006
|
0.76
|
|
61
|
Inotropic contractile reserve and response to cardiac resynchronization therapy in patients with markedly remodeled left ventricle.
|
J Am Soc Echocardiogr
|
2010
|
0.76
|
|
62
|
Antiarrhythmic induced electrical storm in Brugada syndrome: a case report.
|
Ann Noninvasive Electrocardiol
|
2007
|
0.76
|
|
63
|
Ablation vs medical therapy in the setting of symptomatic atrial fibrillation and left ventricular dysfunction.
|
Congest Heart Fail
|
2010
|
0.76
|
|
64
|
Novel pathway for sudden cardiac death prevention.
|
Crit Pathw Cardiol
|
2009
|
0.76
|
|
65
|
Renal denervation for treatment of cardiac arrhythmias: state of the art and future directions.
|
J Cardiovasc Electrophysiol
|
2014
|
0.76
|
|
66
|
Managing atrial fibrillation in the CRT patient: controversy or consensus?
|
Heart Rhythm
|
2012
|
0.76
|
|
67
|
Magnetocardiography throws its hat in the ring.
|
J Cardiovasc Electrophysiol
|
2006
|
0.75
|
|
68
|
Computed tomography imaging of the coronary sinus: a valuable preoperative screen for resynchronization therapy?
|
Cardiol J
|
2011
|
0.75
|
|
69
|
The last shot for "one shot" pulmonary vein isolation with radiofrequency energy?
|
J Cardiovasc Electrophysiol
|
2014
|
0.75
|
|
70
|
Dilemma: how to make use of a CARISMA-tic profile?
|
Europace
|
2011
|
0.75
|
|
71
|
Reply: first-in-humans randomized clinical trial of renal denervation for atrial arrhythmia raises concern.
|
J Am Coll Cardiol
|
2013
|
0.75
|
|
72
|
Intracranial emboli associated with catheter ablation of atrial fibrillation: has the silence finally been broken?
|
J Am Coll Cardiol
|
2011
|
0.75
|
|
73
|
Cardioversion in patients with left ventricular thrombus is not associated with increased thromboembolic risk.
|
J Am Soc Echocardiogr
|
2006
|
0.75
|
|
74
|
Stem cell therapy for electrophysiological disorders.
|
Curr Cardiol Rep
|
2013
|
0.75
|
|
75
|
Evolving concepts in the treatment of atrial fibrillation.
|
Curr Cardiol Rep
|
2003
|
0.75
|
|
76
|
Translation of the RACE pathway for management of atrial fibrillation and atrial flutter into admission forms.
|
Crit Pathw Cardiol
|
2006
|
0.75
|
|
77
|
Activation of the endogenous coagulation system in patients with atrial flutter: relationship to echocardiographic markers of thromboembolic risk.
|
Cardiol J
|
2010
|
0.75
|
|
78
|
Follow-up of robotically assisted left ventricular epicardial leads for cardiac resynchronization therapy.
|
J Am Coll Cardiol
|
2005
|
0.75
|
|
79
|
Clinical utility of a novel wireless implantable loop recorder in the evaluation of patients with unexplained syncope.
|
Heart Rhythm
|
2011
|
0.75
|
|
80
|
The rate control, anticoagulation therapy, and electrophysiology/antiarrhythmic medication pathway for the management of atrial fibrillation and atrial flutter.
|
Crit Pathw Cardiol
|
2005
|
0.75
|
|
81
|
Anatomic substrate, procedural results, and clinical outcome of ultrasound-guided left atrial-pulmonary vein disconnection for treatment of atrial fibrillation.
|
Am J Cardiol
|
2005
|
0.75
|
|
82
|
Treatment of atrial fibrillation in hypertrophic cardiomyopathy.
|
Anadolu Kardiyol Derg
|
2006
|
0.75
|
|
83
|
Temporary Spinal Cord Stimulation to Prevent Postcardiac Surgery Atrial Fibrillation: 30-Day Safety and Efficacy Outcomes.
|
J Am Coll Cardiol
|
2022
|
0.75
|
|
84
|
Cardiac resynchronization therapy in the setting of permanent atrial fibrillation and heart failure.
|
Curr Opin Cardiol
|
2008
|
0.75
|
|
85
|
The impact of nonsustained ventricular tachycardia on reverse remodeling, heart failure, and treated ventricular tachyarrhythmias in MADIT-CRT.
|
J Cardiovasc Electrophysiol
|
2014
|
0.75
|
|
86
|
Very late recurrences of atrial fibrillation after pulmonary vein isolation.
|
Hosp Pract (1995)
|
2010
|
0.75
|
|
87
|
Continuous monitoring of atrial fibrillation in heart failure.
|
Heart Fail Clin
|
2013
|
0.75
|
|
88
|
Computational method to predict esophageal temperature elevations during pulmonary vein isolation.
|
Pacing Clin Electrophysiol
|
2010
|
0.75
|
|
89
|
Images in cardiology: acute anterior wall myocardial infarction in a young male with hypertrophic cardiomyopathy and myocardial bridging.
|
Clin Cardiol
|
2005
|
0.75
|
|
90
|
Cardiac resynchronization therapy and atrial fibrillation.
|
Cardiol J
|
2009
|
0.75
|
|
91
|
The long and winding road.
|
Cardiol J
|
2013
|
0.75
|
|
92
|
Reducing the risk of recurrences after pulmonary vein isolation: what is the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers?
|
Cardiology
|
2010
|
0.75
|
|
93
|
Cardioversion of atrial fibrillation.
|
Prog Cardiovasc Dis
|
2005
|
0.75
|
|
94
|
QT dispersion and viable myocardium in patients with prior myocardial infarction and severe left ventricular dysfunction.
|
Ann Noninvasive Electrocardiol
|
2002
|
0.75
|